Co-found­ed by David Bak­er, Vilya rings in a per­ma­nent CEO; Al­lo­gene names Er­ic Schmidt's CFO suc­ces­sor

→ Ex-Ole­ma On­col­o­gy chief Cyrus Har­mon has resur­faced as CEO of Vilya, a Seat­tle-based macro­cy­cle biotech from David Bak­er’s lab that raised a $50 mil­lion Se­ries A last Au­gust. Har­mon co-found­ed Ole­ma in 2007 and he moved in­to the role of chief tech­nol­o­gy of­fi­cer when Sean Bo­hen was hired as CEO three years ago. He then shift­ed to chief re­search of­fi­cer un­til Ole­ma re­struc­tured in March and laid off about 25% of its staff. CBO Kin­ney Horn joined Har­mon on the chop­ping block, al­though Har­mon is still on Ole­ma’s board of di­rec­tors. For­mer Bris­tol My­ers Squibb ex­ec Nick Mean­well and Ar­rakis chief in­no­va­tion of­fi­cer Jen­nifer Pet­ter are part of Vilya’s sci­en­tif­ic ad­vi­so­ry board.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER